Literature DB >> 10224055

Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors.

G Abuin1, L H Freitas-Junior, W Colli, M J Alves, S Schenkman.   

Abstract

To adapt to different environments, Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, expresses a different set of proteins during development. To begin to understand the mechanism that controls this differential gene expression, we have analyzed the levels of amastin and trans-sialidase mRNAs and the mRNAs encoding members of the 85-kDa glycoprotein gene family, which are differentially expressed in the T. cruzi stages found in the mammalian host. Amastin mRNA is expressed predominantly in intracellular and proliferative amastigotes. trans-Sialidase mRNAs are found mostly in forms undergoing transformation from amastigotes to trypomastigotes inside infected cells, whereas mRNAs encoding the 85-kDa glycoproteins appear only in the infective trypomastigotes released from the cells. The genes coding for these mRNA species are constitutively transcribed in all stages of T. cruzi cells, suggesting that expression is controlled post-transcriptionally during differentiation. Inhibition of transcription by actinomycin D revealed that each mRNA species has a relatively long half-life in stages where it accumulates. In the case of the trans-sialidase and 85-kDa glycoprotein genes, mRNA accumulation was induced by treatment with the protein synthesis inhibitor cycloheximide at the stages that preceded the normal accumulation. Therefore, mRNA stabilization may account for mRNA accumulation. mRNA degradation could be promoted by proteins with high turnover, or stabilization could be promoted by forming a complex with the translational machinery at defined times in development. Identification of the factors that induce mRNA degradation or stabilization is essential to the understanding of control of gene expression in these organisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224055     DOI: 10.1074/jbc.274.19.13041

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.

Authors:  Braulia C Caetano; Bianca B Carmo; Mariane B Melo; Anna Cerny; Sara L dos Santos; Daniella C Bartholomeu; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

2.  85-kDa protein of Trypanosoma cruzi purified by affinity chromatography used in the multiple antigen binding assay (MABA) for the diagnosis of T. cruzi infection in a Venezuelan rural community.

Authors:  Mariolga Berrizbeitia; Brian J Ward; José Bubis; Marcelo Gottschalk; Alberto Aché; Deisy Perdomo; Rafael Medina; Mehudy Medina; Lilian Spencer; Momar Ndao
Journal:  Parasitol Res       Date:  2010-02-24       Impact factor: 2.289

3.  Chromosome localization changes in the Trypanosoma cruzi nucleus.

Authors:  M Carolina Q B Elias; Marcella Faria; Renato A Mortara; Maria Cristina M Motta; Wanderley de Souza; Marc Thiry; Sergio Schenkman
Journal:  Eukaryot Cell       Date:  2002-12

4.  Epigenetic regulation of transcription and virulence in Trypanosoma cruzi by O-linked thymine glucosylation of DNA.

Authors:  Dilrukshi K Ekanayake; Todd Minning; Brent Weatherly; Kapila Gunasekera; Daniel Nilsson; Rick Tarleton; Torsten Ochsenreiter; Robert Sabatini
Journal:  Mol Cell Biol       Date:  2011-02-14       Impact factor: 4.272

5.  Target of rapamycin (TOR)-like 1 kinase is involved in the control of polyphosphate levels and acidocalcisome maintenance in Trypanosoma brucei.

Authors:  Teresa Cristina Leandro de Jesus; Renata Rosito Tonelli; Sheila C Nardelli; Leonardo da Silva Augusto; Maria Cristina M Motta; Wendell Girard-Dias; Kildare Miranda; Paul Ulrich; Veronica Jimenez; Antonio Barquilla; Miguel Navarro; Roberto Docampo; Sergio Schenkman
Journal:  J Biol Chem       Date:  2010-05-21       Impact factor: 5.157

6.  Actively transcribing RNA polymerase II concentrates on spliced leader genes in the nucleus of Trypanosoma cruzi.

Authors:  Fernando de Macedo Dossin; Sergio Schenkman
Journal:  Eukaryot Cell       Date:  2005-05

7.  Characterization of Trypanosoma cruzi Sirtuins as Possible Drug Targets for Chagas Disease.

Authors:  Nilmar Silvio Moretti; Leonardo da Silva Augusto; Tatiana Mordente Clemente; Raysa Paes Pinto Antunes; Nobuko Yoshida; Ana Claudia Torrecilhas; Maria Isabel Nogueira Cano; Sergio Schenkman
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

8.  Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes.

Authors:  C S Eickhoff; L Eckmann; D F Hoft
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Distinct acetylation of Trypanosoma cruzi histone H4 during cell cycle, parasite differentiation, and after DNA damage.

Authors:  Sheila Cristina Nardelli; Julia Pinheiro Chagas da Cunha; Maria Cristina M Motta; Sergio Schenkman
Journal:  Chromosoma       Date:  2009-04-25       Impact factor: 4.316

10.  Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth.

Authors:  Gregory Pedroso Dos Santos; Fernanda Midori Abukawa; Normanda Souza-Melo; Laura Maria Alcântara; Paula Bittencourt-Cunha; Carolina Borsoi Moraes; Bijay Kumar Jha; Bradford S McGwire; Nilmar Silvio Moretti; Sergio Schenkman
Journal:  Cell Microbiol       Date:  2020-12-09       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.